Rashi Pharma Care Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 08-11-2024
- Paid Up Capital ₹ 1.50 M
as on 08-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.90 Cr
as on 08-11-2024
- Revenue 521.95%
(FY 2023)
- Profit 186.85%
(FY 2023)
- Ebitda 185.42%
(FY 2023)
- Net Worth -34.99%
(FY 2023)
- Total Assets 175.54%
(FY 2023)
About Rashi Pharma Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹5.90 Cr.
Shilpa Jain, Rashi Jain, Neeti Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909MH2021PTC356923
- Company No.
356923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rashi Pharma Care?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashi Jain  | Managing Director | 13-Mar-2021 | Current |
| Shilpa Jain | Managing Director | 13-Mar-2021 | Current |
| Neeti Jain | Managing Director | 13-Mar-2021 | Current |
| Sanjay Jain | Managing Director | 13-Mar-2021 | Current |
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance of Rashi Pharma Care.
Rashi Pharma Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 521.95% increase. The company also saw a substantial improvement in profitability, with a 186.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rashi Pharma Care?
Unlock access to Rashi Pharma Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Shreen Biosciences Private LimitedInactive For E-Filing 8 months 16 days
Shilpa Jain and Sanjay Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Jan 2023 | ₹3.75 Cr | Open |
Others Creation Date: 30 Nov 2021 | ₹2.15 Cr | Open |
How Many Employees Work at Rashi Pharma Care?
Rashi Pharma Care has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rashi Pharma Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashi Pharma Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
